Tag: Covaxin

Bhubaneswar: The third phase human trial of Covid-19 vaccine candidate ‘Covaxin’ began at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar on Friday. This is the only institute in the State chosen by the Indian Council for Medical Research (ICMR) for the human trial of the vaccine. The vaccine was administered to two […]

New Delhi: Prime Minister Narendra Modi, today reviewed the preparedness of Covid-19 vaccine delivery, distribution and administration. Prime Minister appreciated the efforts of innovators, scientists, academicians and pharma-companies in their efforts to develop vaccines and has directed that every effort should be made to facilitate the research, development and manufacturing of the vaccine. Five vaccines […]

Bhubaneswar: Even as the race of potential vaccine for Covid-19 is approaching the last lap, the cold-chain infrastructure is likely to emerge as biggest hurdle for Odisha, say experts. The State government has started a road map in full swing for procurement, preservation and distribution of the vaccine as Prime Minister Narendra Modi on Friday […]

New Delhi/Bhubaneswar: Of all the Covid vaccine candidates, who will be the first to achieve a near-complete efficacy is what everyone awaits now. On Monday, the university of Oxford achieved a significant milestone in the fight against Covid. Interim data shows the Oxford vaccine is 70.4 per cent effective, while tests on two dose regimens […]

New Delhi: Hours after Haryana Home and Health Minister Anil Vij, who was administered a dose of Covaxin last month, confirmed that he has been tested positive for coronavirus infection, the Union Health Ministry on Saturday clarified that Vij took only the first dose of the two-dose vaccine. “The antibodies against the infection build up […]

New Delhi: Hyderabad-based Bharat Biotech on Monday filed an application with the Drugs Controller General of India (DCGI) for emergency use authorisation of its Covid-19 vaccine- Covaxin. The application was filed before the apex drug regulator on Monday evening, a company source told IANS on the condition of anonymity. Covaxin, India’s indigenous Covid-19 vaccine by […]

Bhubaneswar: Around 700 vaccination centres were closed down in Odisha after the State ran out of Covid-19 vaccine stock on Wednesday. The vaccination drive was completely disrupted in Koraput district…

New Delhi: Serum Institute of India’s (SII) COVID-19 vaccine candidate – Covishield – has been recommended by the Subject Expert Committee (SEC) which met today to examine the emergency-use authorisation (EUA) application sought by the pharmaceutical firm. With the SEC giving a green signal to Oxford-AstraZeneca’s COVID vaccine candidate, India is one step away from […]

New Delhi: The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech’s ‘Covaxin’ for emergency use in India. However, the final decision on its approval will be taken by the Drug Controller General of India (DCGI). Expert panel recommends granting permission for restricted emergency use authorization for Bharat Biotech’s indigenously […]

Bhubaneswar: As the country’s Covid-19 vaccination plan received a boost with the emergency use nod given to two vaccines – Covishield and Covaxin – by the Subject Expert Committee of the Central Drugs Standard Controller Organsiation (CDSCO), the day also saw a massive mock drill in as many as 125 districts spread across all the […]

New Delhi: The All India Drug Action Network (AIDAN) said it is shocked to learn of the SEC’s recommendation to grant REU approval to Bharat Biotech’s COVAXIN in “clinical trial mode” and “specially in the context of infection by mutant strains”. “In light of the intense concerns arising from the absence of efficacy data and […]

New Delhi: Coronavirus vaccine developed by AstraZeneca and the University of Oxford will cost Rs 219-292 per shot to the government and will be priced at double that rate in private market ones such sales open up, said Adar Poonawalla, the CEO of its Indian manufacturer-Serum Institute of India, on Monday. Serum Institute of India […]

New Delhi: With the Drug Controller General of India (DCGI) approving Serum Institute of India’s ‘Covishield’ vaccine and Bharat Biotech’s ‘Covaxin’ for emergency use, paving way for their roll-out and administration to millions, Russian Sputnik V vaccine makers have said that they are working with AstraZeneca (AZ) to take the efficacy of AZ vaccine to […]

New Delhi: Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccine, Covaxin, to the government for further distribution as the immunisation drive in the country is set to start in coming days, its CMD Dr Krishna Ella said on Monday. “We have already sent the batch to the Central Research Institute in […]

New Delhi: Vaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of COVID-19 vaccines in the country and the world. In a show of solidarity after some bitter comments, Adar Poonawala and Krishna Ella, jointly on behalf of Serum Institute and Bharat Biotech, […]